BLFS
BioLife Solutions Inc
NASDAQ: BLFS · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$19.99
-4.35% today
Updated 2026-04-29
Market cap
$976.66M
P/E ratio
—
P/S ratio
10.15x
EPS (TTM)
$-0.25
Dividend yield
—
52W range
$18 – $30
Volume
0.4M
BioLife Solutions Inc (BLFS) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$19.99
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$20.59
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 14.88% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -4.78%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.